Continued losses in emerging markets sent the domestic markets down to a lower close with the Dow falling 41 points to 15,837. Nasdaq dropped 44 points to 4083.
On the upside
Motley Fool noted that Real Goods Solar (Nasdaq: RSOL) has the potential to soar.
TheStreet affirmed its Buy recommendation for Himax Technologies (Nasdaq: HIMX).
Herbalife's (NYSE: HLF) fourth largest shareholder hired analyst Tim Ramey, a strong supporter of the weight management and nutritional supplement company.
On the downside
An article from TheStreet said that rumors of a possible acquisition of Ariad Pharmaceuticals (Nasdaq: ARIA) were false.
Investors locked in profits on BioCryst Pharmaceuticals (Nasdaq: BCRX).
ThermoGenesis (Nasdaq: KOOL) announced a private placement of 3.33 million common shares at the discounted price of $2.00 per share.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 lost 8 points to 1781. Bitcoin added $3.90 or 0.40% to $969.00.
